ArticleMethods in molecular biology (Clifton, N.J.)2025
High-Throughput Human Cerebrospinal Fluid Proteome Analysis with Direct Data-Independent Acquisition (dDIA).
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebrospinal fluid (CSF) is a low-risk, rapid, and mid-invasive sampling for diagnosis, prognosis, and treatment of neurological pathologies. The CSF liquid biopsies disponibility and sampling homogeneity foster the research for biomarker discovery for neurological disorders and pathologies and, importantly, enable extensive population studies. Liquid chromatography-mass spectrometry (LC-MS) proteomics is a powerful tool for biomarker discovery. Proteomics large studies provide more robust and reliable results, offering exceptional FDR control and outlier identification, allowing high-precision results. Consequently, a robust and reliable pipeline proteomics methodology must be required to analyze hundreds of samples, from sample preparation to data analysis. Here, we describe a detailed workflow for analyzing human CSF samples for large studies by direct data-independent (dDIA).
Indexed as
Identifiers
40167916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.